Seeking Alpha

More on Seattle Genetics (SGEN): Q4 beats across the board on a 30% jump in total sales. Bottom...

More on Seattle Genetics (SGEN): Q4 beats across the board on a 30% jump in total sales. Bottom line numbers were boosted by higher Adcetris sales and lower SG&A expenses, but were offset somewhat by higher R&D costs. Shares +0.6% AH.

Check out Seeking Alpha’s new Earnings Center »

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs